CODE |
DESCRIPTION |
|
IMMUNOELECTROPHORESIS WITH IGA,
IGG, IGM |
|
AFP |
|
CEA |
|
B-HCG |
|
PSA |
|
B2 MICROGLOBULIN |
|
CA-15.3 |
|
CA-125 |
|
CA-19.9 |
|
RANDOM BLOOD GLUCOSE |
|
FASTING BLOOD SUGAR |
|
POST-PRANDIAL BLOOD SUGAR |
|
GLUCOSE TOLERANCE TEST |
|
GLYCOSYLATED HEMOGLOBIN |
|
FASTING URINE SUGAR |
|
POST-PRANDIAL URINE SUGAR |
|
GLUCOCHECK [E.L.] |
|
SERUM CHOLESTEROL |
|
SERUM HDL-CHOLESTEROL |
|
SERUM LDL-CHOLESTEROL |
|
SERUM TRIGLYCERIDES |
|
BLOOD UREA |
|
SERUM URIC ACID |
|
SERUM CREATININE |
|
SERUM SODIUM |
|
SERUM POTASSIUM |
|
SERUM CHLORIDES |
|
SERUM CARBON DIOXIDE/BICARBONATES |
|
SERUM PROTEINS |
|
SERUM ALBUMIN |
|
SERUM GLOBULINS |
|
SERUM ALKALINE PHOSPHATASE |
|
TOTAL BILIRUBIN |
|
DIRECT BILIRUBIN |
|
INDIRECT BILIRUBIN |
|
SERUM S.G.O.T. |
|
SERUM S.G.P.T. |
|
SERUM LDH |
|
SERUM CPK [E.L.] |
|
SERUM CPK-MB [E.L.] |
|
SERUM AMYLASE |
|
SERUM LIPASE |
|
C.S.F. SUGAR |
|
C.S.F. PROTEINS |
|
C.S.F. CHLORIDES |
|
C.S.F. LDH |
|
SERUM CALCIUM |
|
SERUM PHOSPHORUS |
|
SERUM MAGNESIUM |
|
IRON |
|
T.I.B.C. |
|
ACID PHOSPHATASE |
|
PROSTATIC ACID PHOSPHATASE |
|
URINARY VMA |
|
URINARY 5HIAA |
|
ARTERIAL BLOOD GASES [E.L.] |
|
CAPILLARY BLOOD GASES [E.L.] |
|
SERUM LDH [E.L.] |
|
SODIUM (24 HOURS URINE) |
|
POTASSIUM (24 HOURS URINE) |
|
CHLORIDE (24 HOURS URINE) |
|
UREA (24 HOURS URINE) |
|
URIC ACID (24 HOURS URINE) |
|
CREATININE (24 HOURS URINE) |
|
CALCIUM (24 HOURS URINE) |
|
PHOSPHORUS (24 HOURS URINE) |
|
PROTEINS (24 HOURS URINE) |
|
CREATININE CLEARANCE (24 HOURS URINE) |
|
UREA (RANDOM URINE) |
|
URIC ACID (RANDOM URINE) |
|
CREATININE (RANDOM URINE) |
|
SODIUM (RANDOM URINE) |
|
POTASSIUM (RANDOM URINE) |
|
CHLORIDE (RANDOM URINE) |
|
CALCIUM (RANDOM URINE) |
|
PHOSPHORUS (RANDOM URINE) |
|
PROTEINS (RANDOM URINE) |
|
FLUID UREA |
|
FLUID URIC ACID |
|
FLUID CREATININE |
|
FLUID SODIUM |
|
FLUID POTASSIUM |
|
FLUID CHLORIDE |
F940 |
FLUID BILIRUBIN (TOTAL) |
|
FLUID BILIRUBIN (DIRECT) |
|
FLUID BILIRUBIN (INDIRECT) |
|
FLUID CHOLESTEROL |
|
FLUID TRIGLYCERIDE |
|
FLUID HDL CHOLESTEROL |
|
FLUID LDL CHOLESTEROL |
|
SERUM PROTEINS [E.L.] |
|
SERUM ALBUMIN [E.L.] |
|
SERUM GLOBULINS [E.L.] |
|
SERUM ALKALINE PHOSPHATASE [E.L.] |
|
TOTAL BILIRUBIN [E.L.] |
|
SERUM S.G.P.T. [E.L.] |
|
FLUID PROTEINS |
|
FLUID ALBUMIN |
|
FLUID GLOBULIN |
|
FLUID ALKALINE PHOSPHATASE |
|
FLUID O.T. |
|
FLUID P.T. |
|
FLUID CALCIUM |
|
FLUID PHOSPHORUS |
|
FLUID AMYLASE |
|
FLUID LIPASE |
|
FLUID L.D.H. |
|
RANDOM BLOOD SUGAR [E.L.] |
|
FASTING BLOOD SUGAR [E.L.] |
|
POST-PRANDIAL BLOOD SUGAR [E.L.] |
|
SERUM SODIUM [E.L.] |
|
SERUM POTASSIUM [E.L.] |
|
SERUM CHLORIDES [E.L.] |
|
SERUM UREA [E.L.] |
|
SERUM URIC ACID [E.L.] |
|
SERUM CREATININE [E.L.] |
|
SERUM AMYLASE [E.L.] |
|
SERUM LACTATE [E.L.] |
|
SERUM CALCIUM [E.L.] |
|
SERUM MAGNESIUM [E.L.] |
|
SERUM OSMOLALITY |
|
Cytology (F.N.A) |
|
Pap smear cytology |
|
Sputum cytology |
|
Slides for review |
|
Slides for review |
|
Bronchial lavage and / or brushings cytology |
|
Pleural / Pericardial / Peritoneal fluid cytology |
|
Urine, Bladder/ Ureteric / Urethral Washings or Brushing Cytology |
|
Cerebrospinal fluid cytology (CSF) |
|
Oesophageal / GO junction / Anastomotic / Gastric / Colon / Ano-rectal Lavage or Brushing |
|
Nipple discharge cytology |
|
Oral cytology |
|
Bile / CBD Brushings cytology |
|
Fluid / Scrape cytology |
|
Small Biopsy |
|
Big specimen |
|
Outside slides (out In) |
|
Outside slides + Blocks (out In) |
|
Dengue IgG/IgM Antibodies |
|
HIV PCR |
|
Leptospira IgG/IgM Antibodies |
|
Urine examination |
|
Stool Examination |
|
Culture ( Aerobic) |
|
Culture (Fungal) |
|
Drug susceptibility for Mycobacteria |
| G107 |
Routine culture anaerobic |
|
Cultures for Helicobacter pylori |
|
Mantoux test |
|
Culture (AFB) |
|
Culture (AFB) |
|
Widal Test |
|
VDRL |
|
Paul-Bunnel Test |
|
Toxoplasma IgG Antibodies (Toxo IgG) |
|
Toxoplasma IgM Antibodies (Toxo IgM) |
|
Cytomegalovirus IgG Antibodies (CMV IgG) |
|
Cytomegalovirus IgM Antibodies (CMV IgM) |
|
Hepatatis Profile (HBsAg, HBc IgM, HBc IgG total, HCV Antibodies, HAV IgM, HEV IgM) |
|
Hepatitis B Surface Antigen (HBs Ag) |
|
Hepatitis B 'e' Antigen (HBeAg) |
|
Hepatitis B core IgM Antibodies (HBc IgM) |
|
Hepatitis B core Antibodies IgG (HBc IgG Total) |
|
Hepatitis B Surface Antibodies (Anti-HBs) |
|
Hepatitis C Antibodies (Anti HCV) |
|
Hepatitis C Virus RT-PCR |
|
Hepatitis B 'e' Antibodies (Anti-HBe) |
|
Herpes Simplex Virus IgG (HSV IgG) |
|
Herpes Simplex Virus IgM (HSV IgM) |
|
Cryptococcal Antigen by latex agglutination |
|
HPV-DNA (Qualitative) |
|
HBV-DNA (Quantitative) |
|
CMV DNA (Qualitative) |
|
HBV-DNA Qualitative PCR |
| G149 |
OTHER |
|
Fungus Serology |
|
Drug susceptibility for fungus |
|
RA Test |
|
ASO Titres |
|
CRP Titres |
|
Cytomegalovirus Antigenemia Assay (pp65) |
|
HIV Antibodies |
|
Gram's Stain |
|
Ziehl Neelsen (AFB) stain |
|
Lactophenol Cotton Blue |
|
Giemsa Stain |
|
India ink Preparation |
|
Staining for Cryptosporidium, Microsporidium, Isospora spp |
|
Calcofluorwhite staining for Fungus |
|
Potassium hydroxide (KOH) mount |
|
Staining for Pneumocystis |
|
Flouroscent Staining (Auramine-rhodamine, Acridine Orange, Immunofluoroscence) |
|
ADA level (Adenosine Deaminase Activity) |
|
Hepatitis A Virus (IgM Antibodies) |
|
Hepatitis E Virus (IgM Antibodies) |
|
Pregnancy test (Urinary B-HCG) |
|
Antinuclear Antibodies (ANA) |
|
Automated AFB culture |
|
Automated AFB susceptibility(5 drugs) |
|
Automated Blood culture |
|
Blood Grouping |
|
Cross Matching |
|
Testing for Pheresis donors |
|
Coombs Test (Antiglobulin Test ) Direct |
|
Coombs Test (Antiglobulin Test) Indirect |
|
Secretory status |
|
Hepatites B surface Antigen (HBsAg) |
|
Antibody detection of HIV 1 and 2 |
|
Antibody detection of Hepatitis C Virus (HCV) antibody |
|
HLA typing (BMT) ABC &DR |
|
HLA typing (BMT) only ABC |
|
HLA typing (BMT) only DR |
|
HLA typing (BMT) B-27 |
|
HLA DNA typing DNA ¬ DRB1 Low resolution |
|
ESR |
|
PT |
|
PT&PTTK |
|
PT,PTTK,TT |
|
Coagulation profie with D-DIMER, Fibrinogen |
|
Malarial parasite |
|
D-DIMER |
|
Fibrinogen |
|
CSF Cell count and cytomorphology |
|
CBC(3 part differential) |
|
CBC( 5 part differntial) |
|
CBC with MDC |
|
Reticulocyte count |
|
Ascitic fluid cell count and Ascitic fluid cytomorphology |
|
Pleural fluid Cell count and Pleural fluid cytomorphology |
|
Pericardial fluid Cell count and Pericardial fluid cytomorphology |
U751 |
BM Aspitate morphology |
|
Cytochemistry on BM and PBS |
| U753 |
Immunophenotyping on Blood/BM/BF |
| U754 |
Immunophenotyping on Blood/BM/BF Singal Panel |
T101 |
Ph: t(9.22) In Chronic Myeloid Leukaemia (CML) |
| T102 |
CML Blast Crisis |
| T103 |
Acute Myeloid Leukaemia |
| T104 |
Chronic Myelomonocytic Leukaemia |
| T105 |
Myelodysplastic Syndromes |
| T106 |
Myeloproliferative Syndromes |
| T107 |
Chromosomal Breakage (Fragility) Studies In Fanconi's Anaemia, Aplastic Anaemia |
| T108 |
Miscellaneous (Conventional Karyotyping) |
| T201 |
BCR/ABL Ph: t(9;22) (Chronic Myeloid Leukaemia - CML) |
| T202 |
BCR/ABL (Ph) Duplication, Trisomy 8, Trisomy 21, p53 Deletion (CML-Blast Crisis) |
| T203 |
PML/RARA t(15;17) (Acute Promyelocytic Leukaemia - APL, AML M3) |
| T204 |
PML/RARA t(15;17), Variant: t(11;17) / t(5;17) (APL-M3, M3 Variant) |
| T205 |
AML1/ETO t(8;21) (AML M2) |
| T206 |
t(8;21), t(15;17) (AML M2/AML M3) |
| T207 |
BCR/ABL Ph: t(9;22) (Acute Myeloid Leukaemia - AML) |
| T208 |
BCR/ABL Ph: t(15;17) (AML M1/AML M3) |
| T209 |
Inversion (16)/t(16;16) (AML-M4 with Abnormal Eosinophilia, AML M4) |
| T210 |
t(11q23)-MLL Translocations / Rearrangement (AML M4, M5) |
| T211 |
Inversion (16), t(11q23) - MLL Translocation / Rearrangement (AML M4) |
| T212 |
t(8;16) (AML M5b (Acute Monocytic Leukaemia with Phagocytosis)) |
| T213 |
Structural Aberrations of Chromosomes 5, 7, 8 (Myelodysplastic Syndrome-MDS) |
| T214 |
DEL(20)(q12) (Polycythemia Vera) |
| T215 |
MLL Translocation - TEL-AML1, BCR-ABL, AML1-ETO, Ploidy Profile (Acute Leukaemia-AL) |
| T216 |
BCR/ABL Ph: t(9;22) (Acute Lymphoblastic Leukaemia-ALL) |
| T217 |
TEL/AML1 t(12;21) (ALL-B Lineage) |
| T218 |
MLL Translocations/Rearrangement t(11q23) (ALL, Biphenotypic/Therapy Related Leukaemia) |
| T219 |
MLL Translocations/Rearrangement t(11q23), TEL/AML1, BCR/ABL, Ploidy Profile In ALL |
| T220 |
MYC Translocations/Rearrangement t(8;14)/t(8;22)/t(2;8) (Burkitt, NHL Follicular Lymphoma) |
| T221 |
t(14;18) IGH/BCL2 (NHL - Follicular Lymphoma, B-ALL) |
| T222 |
t(14;18) Trisomy 7 (NHL/Follicular Lymphoma) |
| T223 |
t(11;14) IGH/CCND1 (NHL - Mantle Cell Lymphoma) |
| T224 |
t(14;18) IGH/BCL2, t(11;14) IGH/CCND1 (NHL) |
| T225 |
Trisomy 12, DEL(13q14), p53 Deletion Profile (Chronic Lymphocytic Leukaemia (CLL)) |
| T226 |
TRISOMY 12, t(11;14) IGH/CCND1 (Chronic Lymphocytic Leukaemia) |
| T227 |
t(2;5) ALK Translocations/Rearrangement (T-NHL, Anaplastic Large Cell Lymphoma) |
| T228 |
XX or XY Status (Sex-Mismatched BMT, X/Y Disorders) |
| T229 |
Miscellaneous (FISH) |
| T230 |
Miscellaneous Profile I (FISH) |
| T231 |
FLT3 Mutation Study |
| T232 |
JAK2 Mutation Study |
| T233 |
TCR-A |
| T234 |
EVI 1 |
| T235 |
CHIC-2 |
| T236 |
CHIC-2-PDGFRB : t(5;12) rearrangement |
| T237 |
TCR-B : t(7q34) translocation |
| T238 |
t(11;18) API2/MALT1 |
| T239 |
Panel of cytogenetic markers for T-ALL |
| T240 |
Panel of cytogenetic markers for Multiple Myeloma |
| T241 |
EWS : t(11;22) /t(21;22) translocation/rearrangement |
| T242 |
FOXO1 (FKHR) t(2;13)/t(1;13) translocation/rearrangement |
| T243 |
SYT : t(X;18) translocation/rearrangement |
| T244 |
Bladder Cancer/Urothelial carcinoma Marker Profile |
Tata Memorial Hospital, Dr.
E Borges Road, Parel, Mumbai - 400 012 India. 